Trials / Completed
CompletedNCT00170885
Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
Multicenter, Randomized, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Two Regimens of Everolimus Plus Cyclosporine Microemulsion, Given According to Different Blood Target Levels, in de Novo Renal Transplant Recipients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The purpose of the study in de novo renal transplant patients is to evaluate the effect on renal function of an optimized new regimen in comparison with the standard everolimus exposure plus a low-dose cyclosporine microemulsion regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Everolimus |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2007-07-01
- Completion
- 2007-07-01
- First posted
- 2005-09-15
- Last updated
- 2016-11-16
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00170885. Inclusion in this directory is not an endorsement.